PREVALENCE, CAUSE, AND PRESCRIPTION TREND IN PATIENTS WITH UPPER RESPIRATORY TRACT INFECTIONS AND MEMBRANOUS TONSILLITIS. International Research Journal of Pharmacy, [S. l.], v. 4, n. 2, p. 175–180, 2013. DOI: 10.56802/g7sd6f49. Disponível em: https://irjponline.org/index.php/irjp/article/view/3245. Acesso em: 5 nov. 2026.